Marc A Goldberg, MD.,F.A.C.P Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 6 Brighton Rd, 2nd Floor, Clifton, NJ 07012 Phone: 973-777-7911 Fax: 973-777-5403 |
Dr. Michael P Lewko, MD Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 871 Allwood Rd, Clifton, NJ 07012 Phone: 973-405-5163 Fax: 973-365-8004 |
News Archive
A study aimed at better understanding why some critically ill patients develop multidrug-resistant infections is underway by researchers at The University of Texas Health Science Center at Houston.
Merck, known as MSD outside the United States and Canada, today announced that BELSOMRA (suvorexant) is now available at pharmacies in the United States for the treatment of insomnia in adults who have difficulty falling asleep and/or staying asleep.
Cell Therapeutics, Inc. (CTI) announced today that on December 24, 2009, CTI's Board of Directors (the "Board of Directors") approved and adopted a Shareholder Rights Plan (the "Rights Plan") in which one preferred stock purchase right will be distributed for each common share held as of the close of business on January 7, 2010. Initially, the rights are not exercisable, and are attached to and trade with, all of the shares of CTI's common stock outstanding as of, and issued subsequent to, the record date.
Meanwhile, The Hill reports that health lobbying has dropped off compared to the level a year ago when Congress was in the midst of the health reform debate.
› Verified 8 days ago